Galit Reske

Galit Reske, PhD has extensive experience in the field of clinical operations and management. Galit is currently serving as the Director of Clinical Operations at CartiHeal since September 2022. Prior to this role, they worked as the Clinical Operations Manager at CartiHeal from December 2017.

Before joining CartiHeal, Dr. Reske worked at TechnoSTAT LTD. as the Head of Clinical Department from March 2015 to December 2017. In this role, they managed local and global phase I-IV clinical research studies for various pharmaceutical and medical devices companies. Galit'sresponsibilities included project management, supervision and training of study teams, feasibility and site selection, study budget management, and pharmacovigilance & safety reporting.

From January 2012 to March 2015, Dr. Reske worked at Biovo Technologies, Ltd. as a Medical Product Specialist. Galit'sduties included planning, coordinating and implementing clinical trials, preparing documentation for trials, and promoting the usage of clinical products in hospitals.

Dr. Reske's earlier experience includes working at Clinical Consultants Ltd. as a Clinical Trials Manager from January 2007 to December 2011. Galit conducted research on medical products and devices, managed and implemented clinical trials for pharmaceutical companies, and wrote clinical trials protocols and documents.

Galit began their career at Mercury Scientific & Industrial Products Ltd. as the Bioscience Division Manager from January 2003 to August 2005. In this role, they managed sales and marketing activities for biological products, analyzed the market and competitors, developed marketing strategies, and wrote professional marketing materials.

Overall, Dr. Galit Reske has a rich background in clinical operations, project management, and marketing in the pharmaceutical and medical devices industry.

Galit Reske, PhD has a strong educational background in the field of molecular biology. Galit obtained their Bachelor of Science degree in Biology from Bar-Ilan University in 1996. Following this, they pursued their Master of Science degree in Biotechnology from The Hebrew University of Jerusalem, which they completed in 1999. During their master's program, their field of study is not explicitly mentioned. Finally, they successfully earned their Doctor of Philosophy degree in Molecular Biology from The Hebrew University of Jerusalem in 2003. Galit'sdoctoral research focused on the characterization of the apoptosis suppressor protein P49 from the Spodoptera littoralis nucleopolyhedrovirus.